Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 9
1964 8
1965 3
1966 2
1967 15
1968 15
1969 19
1970 22
1971 27
1972 19
1973 22
1974 23
1975 8
1976 11
1977 16
1978 13
1979 9
1980 17
1981 15
1982 8
1983 27
1984 24
1985 16
1986 13
1987 28
1988 27
1989 41
1990 42
1991 41
1992 38
1993 43
1994 43
1995 66
1996 42
1997 74
1998 46
1999 52
2000 65
2001 59
2002 57
2003 62
2004 76
2005 80
2006 82
2007 59
2008 49
2009 68
2010 85
2011 70
2012 84
2013 74
2014 87
2015 70
2016 58
2017 93
2018 79
2019 82
2020 78
2021 70
2022 74
2023 75
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

2,548 results

Results by year

Filters applied: . Clear all
Page 1
Personalized Management of Pheochromocytoma and Paraganglioma.
Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K. Nölting S, et al. Endocr Rev. 2022 Mar 9;43(2):199-239. doi: 10.1210/endrev/bnab019. Endocr Rev. 2022. PMID: 34147030 Free PMC article. Review.
A further 35% to 40% of Caucasian patients (a higher percentage in the Chinese population) are affected by somatic driver mutations. Thus, around 70% of all patients with pheochromocytoma/paraganglioma can be assigned to 1 of 3 main molecular clusters with different phenot …
A further 35% to 40% of Caucasian patients (a higher percentage in the Chinese population) are affected by somatic driver mutations. Thus, a …
Pheochromocytoma and Paraganglioma.
Neumann HPH, Young WF Jr, Eng C. Neumann HPH, et al. N Engl J Med. 2019 Aug 8;381(6):552-565. doi: 10.1056/NEJMra1806651. N Engl J Med. 2019. PMID: 31390501 Review. No abstract available.
Pheochromocytoma.
Farrugia FA, Charalampopoulos A. Farrugia FA, et al. Endocr Regul. 2019 Jul 1;53(3):191-212. doi: 10.2478/enr-2019-0020. Endocr Regul. 2019. PMID: 31517632 Free article. Review.
Pheochromocytoma, diagnosis and treatment: Review of the literature.
Farrugia FA, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos E, Zavras N, Sotiropoulos D. Farrugia FA, et al. Endocr Regul. 2017 Jul 1;51(3):168-181. doi: 10.1515/enr-2017-0018. Endocr Regul. 2017. PMID: 28858847 Free article. Review.
RESULTS: More than four times elevation of plasma fractionated metanephrines or elevated 24-h urinary fractionated metanephrines are keys to diagnosing pheochromocytoma. If the results are equivocal then we perform the clonidine test. ...If there is a risk of the hereditab …
RESULTS: More than four times elevation of plasma fractionated metanephrines or elevated 24-h urinary fractionated metanephrines are keys to …
Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Mete O, et al. Endocr Pathol. 2022 Mar;33(1):90-114. doi: 10.1007/s12022-022-09704-6. Epub 2022 Mar 13. Endocr Pathol. 2022. PMID: 35285002 Review.
This classification discusses the embryologic derivation of the cells that give rise to these lesions and the historical evolution of the terminology used to classify their tumors; paragangliomas can be sympathetic or parasympathetic and the term pheochromocytoma is used s …
This classification discusses the embryologic derivation of the cells that give rise to these lesions and the historical evolution of the te …
Phaeochromocytoma.
Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Lenders JW, et al. Lancet. 2005 Aug 20-26;366(9486):665-75. doi: 10.1016/S0140-6736(05)67139-5. Lancet. 2005. PMID: 16112304 Review.
Perioperative Management of Pheochromocytoma.
Naranjo J, Dodd S, Martin YN. Naranjo J, et al. J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1427-1439. doi: 10.1053/j.jvca.2017.02.023. Epub 2017 Feb 4. J Cardiothorac Vasc Anesth. 2017. PMID: 28392094 Review.
This review focuses on the perioperative management of pheochromocytoma/paragangliomas, initially summarizing the clinical aspects of the disease and then highlighting the current evidence available for preoperative, intraoperative, and postoperative anesthetic management. …
This review focuses on the perioperative management of pheochromocytoma/paragangliomas, initially summarizing the clinical aspects of …
Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician.
Sharma S, Fishbein L. Sharma S, et al. Endocr Pract. 2023 Dec;29(12):999-1006. doi: 10.1016/j.eprac.2023.07.027. Epub 2023 Aug 15. Endocr Pract. 2023. PMID: 37586639 Review.
METHODS: A literature search of PubMed was carried out using key words, including pheochromocytoma, paraganglioma, treatment, diagnosis, screening, and management. ...
METHODS: A literature search of PubMed was carried out using key words, including pheochromocytoma, paraganglioma, treatment, diagnos …
2,548 results